MIKEL
GASTACA MATEO
PROFESORADO ASOCIADO
Hospital Universitari de Bellvitge
l'Hospitalet de Llobregat, EspañaPublications in collaboration with researchers from Hospital Universitari de Bellvitge (13)
2024
2023
-
Alternative forms of portal vein revascularization in liver transplant recipients with complex portal vein thrombosis
Journal of Hepatology, Vol. 78, Núm. 4, pp. 794-804
2022
-
Abdominal normothermic regional perfusion in controlled donation after circulatory determination of death liver transplantation: Outcomes and risk factors for graft loss
American Journal of Transplantation, Vol. 22, Núm. 4, pp. 1169-1181
-
Cumulative exposure to tacrolimus and incidence of cancer after liver transplantation
American Journal of Transplantation, Vol. 22, Núm. 6, pp. 1671-1682
2021
-
Epidemiological pattern, incidence, and outcomes of COVID-19 in liver transplant patients
Journal of Hepatology, Vol. 74, Núm. 1, pp. 148-155
2019
-
Normothermic regional perfusion vs. super-rapid recovery in controlled donation after circulatory death liver transplantation
Journal of Hepatology, Vol. 70, Núm. 4, pp. 658-665
-
Reply to: “Normothermic regional perfusion – What is the benefit?”
Journal of Hepatology
-
The UK DCD Risk Score: Still no consensus on futility in DCD liver transplantation
Journal of Hepatology
2016
-
Liver Retransplantation in Patients with HIV-1 Infection: An International Multicenter Cohort Study
American Journal of Transplantation, Vol. 16, Núm. 2, pp. 679-687
2015
-
Impact of tacrolimus and mycophenolate mofetil regimen vs. a conventional therapy with steroids on cardiovascular risk in liver transplant patients
Clinical Transplantation, Vol. 29, Núm. 8, pp. 667-677
-
V Reunión de Consenso de la Sociedad Española de Trasplante Hepático sobre receptores de riesgo elevado, escenarios actuales de inmunosupresión y manejo del hepatocarcinoma en espera de trasplante
Cirugia Espanola, Vol. 93, Núm. 10, pp. 619-637
2014
-
"very early" intrahepatic cholangiocarcinoma in cirrhotic patients: Should liver transplantation be reconsidered in these patients?
American Journal of Transplantation, Vol. 14, Núm. 3, pp. 660-667
-
Intrahepatic cholangiocarcinoma or mixed hepatocellular-cholangiocarcinoma in patients undergoing liver transplantation: A spanish matched cohort multicenter study
Annals of Surgery, Vol. 259, Núm. 5, pp. 944-952